Arkolith/Insider Trading/VERA/Form 4

Fordyce Marshall

PRESIDENT AND CEO, DirectorVera Therapeutics, Inc. (VERA) · full profile →Form 4 · filed Jan 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$730K
Net Open-Market Flow
-$730K
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 8, 2025Option exercise(M)10K$2.90$29K154K
Jan 8, 2025Sell(S)10K$41.53$414K144K
Jan 8, 2025Sell(S)2K$42.00$79K144K
Jan 8, 2025Sell(S)6K$42.03$237K144K
Jan 8, 2025Option exercise(M)2K$2.90$5K145K
Jan 8, 2025Option exercise(M)6K$2.90$16K149K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 8, 2025Option exercise(M)2K—$0609K
Jan 8, 2025Option exercise(M)16K—$0611K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-001242) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML